-
BCR-ABL P190 ELITe MGB Kit
The product of the Philadelphia translocation, the BCR/ABL oncogene P190 isoform, is commonly found in acute lymphoid leukemia, a rare disease that can be fatal within a matter of months if untreated. Detection and quantification of P190 BCR-ABL fusion gene, by molecular methods, is crucial for patient management, to initiate the appropriate treatment and measure response to therapy.
-
BCR-ABL P210 ELITe MGB Kit
The product of the Philadelphia translocation, the BCR/ABL oncogene P210 isoform, is typically found in chronic myelogenous leukemia, and in acute lymphoid and myeloid leukemia, causing the cells to divide uncontrollably and inducing severe outcomes among patients. Detection and quantification of P210 BCR-ABL fusion gene, by molecular methods, is crucial for patient management, to initiate the appropriate treatment, measure the response to therapy and predict relapse
-
ELITe InGenius – Sample to Result
ELITe InGenius is an open, flexible, and easy to use sample-to-result solution for standardizing complex real-time PCR assay procedures.
ELITe InGenius automatically performs nucleic acid extraction, quantitative PCR, and results interpretation on a single platform for unprecedented flexibility and efficiency.
ELITe InGenius combines universal extraction with multiple independently controlled PCRs enabling laboratories to run a virtually unlimited menu of unique custom assays with a single workflow.
-
EM Smart-Reader™
MUCH MORE THAN A READER…
A unique Microbiology Expertise Now Embodied in a Smart and Reliable Solution.
-
Ingenius MDR/MTB ELITe MGB Kit
Tuberculosis is a major and underdiagnosed health issue commonly caused by species belonging to the Mycobacterium tuberculosis. The steady increase of resistant forms, caused by intensive use of frontline antibiotics such as rifampicin and isoniazid, is particularly alarming and leads to massive treatment failure. Rapid and reliable detection of patients infected with MTB and resistance to rifampicin and isoniazid, is essential to determine the right therapy and limit the use of inappropriate treatments.
-
Ingenius Respiratory Bacterial ELITe MGB Panel
Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionellapneumophila are common bacteria involved in respiratory infections, and responsible for severe complications, especially in the immunocompromised. Symptoms of respiratory infections are similar, non-specific, and not sufficient to clearly identify the causative agent. Molecular methods are the most efficient solutions to identify the right pathogen and provide an adapted patient treatment.
-
Ingenius Respiratory Viral ELITe MGB Panel
Influenza A, influenza B and Respiratory syncytial viruses are the most common cause of acute respiratory infections. These respiratory viruses can also cause serious complications among persons with weak immune systems, such babies and the elderly. Simultaneous detection of Flu A, Flu B and HRSV A/B with molecular testing methods is important, to better manage patients and control infections.
-
MYCOFAST RevolutioN
Detection, enumeration, identification and complete antimicrobial susceptibility testing of urogenital mycoplasma: DIRECT METHOD
The MYCOFAST® RevolutioN is an accurate, cost-effective, easy-to-use colorimetric assay designed for the detection, enumeration, identification and antibiotic susceptibility determination of Ureaplasma urealyticum (U.u.) and Mycoplasma hominis (M.h.) from urogenital specimens.
The MYCOFAST® RevolutioN enables labs to determine susceptibility to a panel of new antibiotics, helping physicians comply with the latest therapeutic guidelines from CLSI (Clinical Laboratories Standards Institute). The addition of the MYCOFAST® RevolutioN expands ELITech’s family of mycoplasma test solutions, offering the most extensive antibiotic susceptibility determination at key clinical end-points.
-
STI ELITe MGB Panel
STI ELITe MGB® Panel is a triplex PCR assay designed to detect and differentiate Chlamydia trachomatis, including the Swedish variant, Neisseria gonorrhoeae and Mycoplasma genitalium DNAs. The assay is CE-IVD validated on urine samples and cervical swabs*, in combination with ELITe InGenius®, a fully automated sample-to-result solution.
- Home
- Products
- Sectors
- Clinical Laboratories
- Industry & Research Labs
- Test Parameters
- Partners
- Biomerieux
- Greiner
- VWR
- Aptaca
- Biolife
- Waters
- Honeywell
- Gesan
- Isolab
- Randox
- Macopharma
- Mediwiss
- Polatom
- Kima
- Sigma Centrifugen
- Mast GRP
- Tecna
- CTK
- Hain Lifescience
- Vicam
- DNA Technology
- Dirui
- Elitech
- Sifin
- Microgen
- Chromsystems
- Barchemicals
- Analytik Jena
- Instrumentation Laboratory
- Bag Health
- Hach Lange
- Ahlstrom
- Fast Track Diagnostics
- Wako Chemicals
- Xylem
- Memmert
- Alkaloid
- Brand
- Eppendorf
- Binder
- About Us
- Blog
- Contact Us